Cytokine & Growth Factor Reviews

Papers
(The median citation count of Cytokine & Growth Factor Reviews is 11. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
COVID-19: From emerging variants to vaccination193
Editorial Board147
Potential effects of HMGB1 on viral replication and virus infection-induced inflammatory responses: A promising therapeutic target for virus infection-induced inflammatory diseases134
Unveiling cytokine charge disparity as a potential mechanism for immune regulation122
Targeting the metabolism and immune system in pancreatic ductal adenocarcinoma: Insights and future directions120
Navigating IL-6: From molecular mechanisms to therapeutic breakthroughs114
Editorial Board101
Metabolic Regulation of cGAS-STING Signaling in the Tumor Microenvironment: Dual Immune Roles and Therapeutic Implications96
CDK4/6 inhibition in hormone receptor-positive/HER2-negative breast cancer: Biological and clinical aspects87
Proteomics analysis of circulating small extracellular vesicles: Focus on the contribution of EVs to tumor metabolism85
Editorial Board75
Editorial Board75
Insights into IL-6/JAK/STAT3 signaling in the tumor microenvironment: Implications for cancer therapy67
Progranulinopathy: A diverse realm of disorders linked to progranulin imbalances67
Participation of interferons in psoriatic inflammation66
Epithelial-to-mesenchymal transition transcription factors: New strategies for mesenchymal tissue regeneration61
Cytokine symphony: Deciphering the tumor microenvironment and metastatic axis in oral cancer61
Immuno-metabolic control of the balance between Th17-polarized and regulatory T-cells during HIV infection59
Molecular mechanisms of regulation of IL-1 and its receptors57
Natural killers or natural regulators? Dual roles of NK cells in checkpoint immunotherapy57
Central role of Galectin-3 at the cross-roads of cardiac inflammation and fibrosis: Implications for heart failure and transplantation56
Pro-angiogenic activity and vasculogenic mimicry in the tumor microenvironment by leptin in cancer54
TGF-β mediated drug resistance in solid cancer51
Novel insights into neuroinflammatory mechanisms in traumatic brain injury: Focus on pattern recognition receptors as therapeutic targets44
Exogenous drug-induced mouse models of atopic dermatitis44
Scarless wound healing: Current insights from the perspectives of TGF-β, KGF-1, and KGF-244
The cGAS-STING pathway: Post-translational modifications and functional implications in diseases43
Chemokines and chemokine receptors: Insights from human disease and experimental models of helminthiasis42
Immunosuppressive tumor microenvironment and uterine fibroids: Role in collagen synthesis42
Current utilization of interferon alpha for the treatment of coronavirus disease 2019: A comprehensive review42
MDSCs might be “Achilles heel” for eradicating CSCs37
Suppressor of cytokine signaling 6 in cancer development and therapy: Deciphering its emerging and suppressive roles37
Tumor microenvironment, histone modifications, and myeloid-derived suppressor cells36
Exosomes as a modulator of immune resistance in human cancers36
COVID-19 and dys-regulation of pulmonary endothelium: implications for vascular remodeling36
Exosomes: Another intercellular lipometabolic communication mediators in digestive system neoplasms?35
Multifaceted role of CD14 in innate immunity and tissue homeostasis35
Netrin-1: An emerging player in inflammatory diseases34
Decoding the roles of heat shock proteins in liver cancer32
The IFN-γ/miniTrpRS signaling axis: An insight into the pathophysiology of osteoporosis and therapeutic potential32
Modulation of IL-33/ST2 signaling as a potential new therapeutic target for cardiovascular diseases32
B cell-activating factor and its targeted therapy in autoimmune diseases32
Editorial Board31
The roles of cell-cell and organ-organ crosstalk in the type 2 diabetes mellitus associated inflammatory microenvironment30
Quantitative and qualitative differences in the activation of a fibroblast growth factor receptor by different FGF ligands30
Crosstalk between ferroptosis and the epithelial-mesenchymal transition: Implications for inflammation and cancer therapy30
Exploring inflammatory and fibrotic mechanisms driving diabetic nephropathy progression30
Nuclear translocation of RON receptor tyrosine kinase. New mechanistic and functional insights29
The impact of adipokines on vascular networks in adipose tissue29
Forgetting COVID-19 – Introduction to the special issue28
Liquid biopsy analysis of lipometabolic exosomes in pancreatic cancer27
Exosomal noncoding RNA-mediated spatiotemporal regulation of lipid metabolism: Implications in immune evasion and chronic inflammation27
Extracellular vesicles: Emerging mediators of cell communication in gastrointestinal cancers exhibiting metabolic abnormalities26
Therapeutic inhibition of the JAK-STAT pathway in the treatment of inflammatory bowel disease26
The role of Extracellular Vesicles in glycolytic and lipid metabolic reprogramming of cancer cells: Consequences for drug resistance26
mTOR in programmed cell death and its therapeutic implications25
Role of exosomes in transferring chemoresistance through modulation of cancer glycolytic cell metabolism25
Cholecystokinin and gastrin as immune modulating hormones: Implications and applications25
Nefarious NTRK oncogenic fusions in pediatric sarcomas: Too many to Trk24
Ferroptosis in immune cells: Implications for tumor immunity and cancer therapy24
Exosomes-regulated lipid metabolism in tumorigenesis and cancer progression24
Mechanisms and routes of G-protein coupled receptor-mediated Tau degradation in Alzheimer’s disease23
Glioblastoma-associated macrophages: A key target in overcoming glioblastoma therapeutic resistance23
Editorial Board23
The journey of STING: Guiding immune signaling through membrane trafficking23
Interleukin-17: A pleiotropic cytokine implicated in inflammatory, infectious, and malignant disorders23
JAK inhibitors in immune regulation and treatment of vitiligo22
The role and transformative potential of IL-19 in atherosclerosis22
Multiple post-translational modifications ensure EGFR functionality: Potential therapeutic targets to overcome its drug-resistance mutations22
Regulation of regulated cell death by extracellular vesicles in acute kidney injury and chronic kidney disease22
Alternative pathways driven by STING: From innate immunity to lipid metabolism21
The IL-2A receptor pathway and its role in lymphocyte differentiation and function21
Could IL-25 be a potential therapeutic target for intestinal inflammatory diseases?21
Crosstalk between lncRNAs in the apoptotic pathway and therapeutic targets in cancer21
Unraveling the intricacies of neutrophil extracellular traps in inflammatory bowel disease: Pathways, biomarkers, and promising therapies21
Leptin as a mechanistic link between obesity and systemic lupus erythematous20
Cancer-associated fibroblasts: Vital suppressors of the immune response in the tumor microenvironment20
An emerging paradigm of CXCL16 involvement in cancer progression20
The critical role of osteopontin (OPN) in fibrotic diseases20
GLP-1R agonist therapy and vaccine response: Neglected implications20
Uncovering key mechanisms and intervention therapies in aging skin20
The activin-follistatin system: Key regulator of kidney development, regeneration, inflammation, and fibrosis19
Decoding the neuroimmune axis in colorectal cancer: From neural circuitry to therapeutic innovation19
The functional roles of m6A modification in T lymphocyte responses and autoimmune diseases19
T cell receptor signaling in the differentiation and plasticity of CD4+ T cells18
Editorial Board18
Retard or exacerbate: Role of long non-coding RNA growth arrest-specific 5 in the fibrosis18
Macrophage migration inhibitor factor (MIF): Potential role in cognitive impairment disorders17
Endothelial and macrophage interactions in the angiogenic niche17
The anti-inflammatory effects of itaconate and its derivatives in neurological disorders17
Role of lipid signalling in extracellular vesicles-mediated cell-to-cell communication16
The central role of CXCL10-CXCR3 signaling in neuroinflammation and neuropathology16
Pharmacological therapies and drug development targeting SARS-CoV-2 infection16
FGF/FGFR signaling: From lung development to respiratory diseases16
Cytokines and soluble mediators as architects of tumor microenvironment reprogramming in cancer therapy16
Recent progress and prospects for anti-cytokine therapy in preclinical and clinical acute lung injury16
LC3B: A microtubule-associated protein influences disease progression and prognosis16
Cytokines on the way to secretion15
SARS-CoV-2 infection and oxidative stress: Pathophysiological insight into thrombosis and therapeutic opportunities15
Assessment of clinical studies evaluating combinations of immune checkpoint inhibitors with locoregional treatments in solid tumors15
Immune evasion of neutralizing antibodies by SARS-CoV-2 Omicron15
The impact of cytokines in neuroinflammation-mediated stroke15
Revisiting IRF1-mediated antiviral innate immunity15
Exosome-mediated metabolic reprogramming: Implications in esophageal carcinoma progression and tumor microenvironment remodeling15
Interleukin-33/serum stimulation-2 pathway: Regulatory mechanisms and emerging implications in immune and inflammatory diseases15
Glycosylation of FGF/FGFR: An underrated sweet code regulating cellular signaling programs15
Extracellular vesicles as mediators of cell-cell communication in ovarian cancer and beyond – A lipids focus14
The involvement of TH17 cells in the pathogenesis of IBD14
The Coronavirus pandemic – 2022: Viruses, variants & vaccines14
The interleukin-1 cytokine family members: Role in cancer pathogenesis and potential therapeutic applications in cancer immunotherapy14
Targeting interleukin-17 in radiation-induced toxicity and cancer progression13
TLR-based therapeutic strategies for hepatocellular carcinoma13
Role of growth factors and their interplay during oligodendroglial differentiation and maturation13
BCR-ABL: The molecular mastermind behind chronic myeloid leukemia12
Preexisting immunity: Barrier or bridge to effective oncolytic virus therapy?12
Unveiling the role of IL-17: Therapeutic insights and cardiovascular implications12
The odyssey of cGAS: From cytosol to nucleus12
Neuroprotective properties of ciliary neurotrophic factor in the retina for the treatment of macular telangiectasia type 212
The role of microglial activation on ischemic stroke: Modulation by fibroblast growth factors11
Granulocyte macrophage colony stimulating factor in virus-host interactions and its implication for immunotherapy11
Mechanisms of NLRP3 inflammasome activation and the development of peptide inhibitors11
Cardiac and pericardial inflammatory changes and post-cardiac surgery atrial fibrillation11
0.07233190536499